L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités

Archive

✕

28 mars 2020, 16:12

86

Abbott launches new point of care Coronavirus test with results in five minutes

Abbott launches new point of care Coronavirus test with results in five minutes

The US Food and Drug Administration (FDA) has approved a new point of care test from Abbott that can provide a SARS-CoV-2 result in as little as five minutes. The molecular test runs on Abbott's established ID NOW platform which can be used in a clinical setting or, thanks ...

28 mars 2020, 15:53

93

HIV conferences cancelled amid global pandemic

HIV conferences cancelled amid global pandemic

Three HIV conferences due to take place this Spring/Summer have been cancelled as the Coronavirus pandemic continues to wreak havoc around the world. Both the International AIDS Society (IAS) AIDS 2020 conference in San Francisco, scheduled for July, and the HIV 2020 ...

27 mars 2020, 08:58

165

Gilead withdraws their Orphan Drug Status application for hope COVID-19 treatment, Remdesivir.

Gilead withdraws their Orphan Drug Status application for hope COVID-19 treatment, Remdesivir.

As we reported earlier this week the US Food & Drug Administration (FDA) granted Gilead Sciences' application to grant their antiviral treatment, Remdesivir, Orphan Drug Status. Yesterday, however, Gilead Sciences asked the FDA to revoke the special status after facing ...

24 mars 2020, 13:29

283

Special status given to COVID-19 drug, Remdesivir, causes cost and supply concerns

Special status given to COVID-19 drug, Remdesivir, causes cost and supply concerns

The US Food and Drug Administration (FDA) has granted Gilead Sciences "orphan" drug status for their antiviral drug, Remdesivir, causing concern over what this means for access and pricing for the promising COVID-19 treatment. The "orphan" drug designation is intended ...

24 mars 2020, 13:20

195

World Health Organisation launches large trial into COVID-19 treatments

World Health Organisation launches large trial into COVID-19 treatments

The World Health Organisation (WHO) has launched a huge trial, called SOLIDARITY, to assess the efficacy of four different treatments against SARS-CoV-2 (the Coronavirus) and COVID-19. The four treatments that the WHO will be studying are: 1. Remdesivir (an experimental ...

16 mars 2020, 14:29

436

Urgent call to patients on Kaletra

Urgent call to patients on Kaletra

Kaletra is urgently needed to treat patients infected with the coronavirus (COVID19). The clinics don't have enough supplies. Please bring back to the clinic all the Kaletra you have in stock immediately and have your HIV therapy changed. If a therapy switch is not possible, ...

13 mars 2020, 13:51

723

CROI 2020: COVID-19 Special Session

CROI 2020: COVID-19 Special Session

Last Tuesday, March 10, at a conference in the United States on retroviruses and opportunistic infections (CROI 2020), a special session was held on the novel coronavirus and the condition known as COVID-19. Four reports were presented on key aspects of the epidemiology ...

13 mars 2020, 13:01

5337

People living with HIV at no greater risk of COVID-19, than general population

People living with HIV at no greater risk of COVID-19, than general population

There is no evidence that people living with HIV are at greater risk of COVID-19, or more severe disease if affected, than the general population. That’s the message from the British HIV Association (BHIVA) who released updated guidance on the matter today. Data presented ...

12 mars 2020, 11:16

360

Levels of HIV fall in Australia thanks to Treatment As Prevention (TASP)

Levels of HIV fall in Australia thanks to Treatment As Prevention (TASP)

Data presented at CROI 2020, this week, has shown the impacts of Treatment as Prevention (TASP) on both new HIV diagnoses and community viremia (the number of people living with transmittable levels of HIV) in Australia. The study showed a significant decrease in active ...

10 mars 2020, 12:32

505

The London Patient, the second person cured of HIV, reveals identity

The London Patient, the second person cured of HIV, reveals identity

The man, previously known only as 'The London Patient' who was the second person in the world to be cleared of HIV has revealed his identity this week. Adam Castillejo, who still wishes to be known as 'The London Patient' has been confirmed to be in long-term remission ...

1 2 3...95